These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22981045)

  • 1. Pro-inflammatory cytokine profile of critically ill septic patients following therapeutic plasma exchange.
    Hamishehkar H; Beigmohammadi MT; Abdollahi M; Mousavi S; Ziaie S; Sharifian RA; Davoudi S; Mojtahedzadeh M
    Transfus Apher Sci; 2013 Feb; 48(1):75-8. PubMed ID: 22981045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory cytokine levels in patients with septic shock.
    Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating monocytes are not the major source of plasma cytokines in patients with sepsis.
    Gille-Johnson P; Smedman C; Gudmundsdotter L; Somell A; Nihlmark K; Paulie S; Andersson J; Gårdlund B
    Shock; 2012 Dec; 38(6):577-83. PubMed ID: 23143060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsis.
    Butty VL; Roux-Lombard P; Garbino J; Dayer JM; Ricou B;
    Eur Cytokine Netw; 2003; 14(1):15-9. PubMed ID: 12799209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
    Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
    Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vipera aspis venom reduces lethality and down-regulates tumor necrosis factor-alpha in a rat model of LPS-induced sepsis.
    Frolkis I; Klein Y; Locker C; Adi N; Dahan E; Uretzsky G; Shapira I; Sorkine P
    Cytokine; 2010 Mar; 49(3):319-24. PubMed ID: 20034812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children.
    Aygün F; Varol F; Durak C; Talip Petmezci M; Kacar A; Dursun H; Irdem A; Çokuğraş H; Camcıoğlu Y; Çam H
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284692
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis.
    Zagli G; Bonizzoli M; Spina R; Cianchi G; Pasquini A; Anichini V; Matano S; Tarantini F; Di Filippo A; Maggi E; Peris A
    Minerva Anestesiol; 2010 Jun; 76(6):405-12. PubMed ID: 20473253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study.
    Graziani G; Bordone G; Bellato V; Finazzi S; Angelini C; Badalamenti S;
    J Nephrol; 2006; 19(2):176-82. PubMed ID: 16736416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA; Drosou E; Bassaris HP; Skoutelis A
    J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 13 and inflammatory markers in human sepsis.
    Collighan N; Giannoudis PV; Kourgeraki O; Perry SL; Guillou PJ; Bellamy MC
    Br J Surg; 2004 Jun; 91(6):762-8. PubMed ID: 15164448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical and Laboratory Efficacy of HA 330 Treatment Combined with Continuous Renal Replacement Therapy in Septic Shock Patients: A Case Series.
    Onuk S; Akin AK; Sari A; Gundogan K; Baskol G; Dogru K; Sungur M
    Blood Purif; 2023; 52(2):140-147. PubMed ID: 36634624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].
    Wang CT; Ren HS; Jiang JJ; Zhang JC; Meng M; Yu JB; Chu YF; Ding M
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):421-4. PubMed ID: 19615135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model.
    Li M; Xue J; Liu J; Kuang D; Gu Y; Lin S
    Ther Apher Dial; 2011 Feb; 15(1):98-108. PubMed ID: 21272259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome.
    Stegmayr B
    Transfus Apher Sci; 2008 Jun; 38(3):203-8. PubMed ID: 18492616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
    Zeerleder S; Hack CE; Caliezi C; van Mierlo G; Eerenberg-Belmer A; Wolbink A; Wuillenmin WA
    Clin Immunol; 2005 Aug; 116(2):158-65. PubMed ID: 15993363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?
    Routsi C; Giamarellos-Bourboulis EJ; Antonopoulou A; Kollias S; Siasiakou S; Koronaios A; Zakynthinos S; Armaganidis A; Giamarellou H; Roussos C
    Clin Exp Immunol; 2005 Oct; 142(1):62-7. PubMed ID: 16178857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.
    Soni A; Pepper GM; Wyrwinski PM; Ramirez NE; Simon R; Pina T; Gruenspan H; Vaca CE
    Am J Med; 1995 Mar; 98(3):266-71. PubMed ID: 7872343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.